Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses
暂无分享,去创建一个
A. Faggiano | A. Colao | G. Lombardi | L. Camera | D. Ferone | G. Angeletti | M. C. Bellucci | V. Ramundo | F. Grimaldi | L. Camera | P. Ferollà | R. Severino | G. Scarpelli | P. Ferolla | V. Ramundo | G. Angeletti | M. Bellucci | P. Ferolla